ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).
The ZOLL LifeVest ® team is “going red” for Heart Month in February 2026 in support of the American Heart Association and their Go Red for Women ® initiative to spotlight women's cardiac health. ZOLL ...
Backed by decades of continuous innovation informed by patient feedback, LifeVest continues to set the standard in the WCD market. LifeVest delivers highly effective, safe therapy for patients at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results